TrialPloS one2017

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.

María Buti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.